A combination drug of Vildagliptin (a DPP-4 inhibitor) and Metformin (a biguanide) that belongs to the anti-diabetic class is called Glipy Met 500 SR Tablet. Non-insulin-dependent diabetes mellitus (NIDDM) or maturity-onset diabetes are other names for type 2 diabetes. When your body does not create enough insulin or when your body's insulin does not function as it should, type 2 diabetes can occur. It can also arise from an overabundance of glucagon produced by the body. Particularly after a meal, the hormone insulin aids in lowering blood sugar levels. Another drug that stimulates the liver's synthesis of sugar and raises blood sugar is Glipy Met 500 SR Tablet. Both of these are produced by the pancreas.

Usage instructions-

• Read the pack carefully and use as directed by your doctor.

How it works-

Metformin and Vildagliptin are the two anti-diabetic drugs included in the Glipy Met 500 SR Tablet. Biguanide, an anti-diabetic drug, is metformin. It works by decreasing the amount of glucose the liver can make, lowering the rate at which glucose is absorbed by the intestines, and increasing the body's sensitivity to insulin. Vildagliptin, a DPP-4 inhibitor, reduces hormones that raise blood sugar levels while simultaneously promoting pancreatic insulin release. This decreases blood sugar levels both after meals and when fasting. They provide better blood sugar management when used together.

Safety information-

Pregnancy

It is recommended to consult your doctor before taking it during pregnancy.

Kidney

It is advised to consult your doctor before taking this medicine if you have any kidney issue.

Liver

If you have any concerns about using this medicine in patients with liver impairment, please consult your doctor.